» Articles » PMID: 24519204

Effect of the Systemic Administration of Methylprednisolone on the Lungs of Brain-dead Donor Rats Undergoing Pulmonary Transplantation

Abstract

Objective: Most lung transplants are obtained from brain-dead donors. The physiopathology of brain death involves hemodynamics, the sympathetic nervous system, and inflammatory mechanisms. Administering methylprednisolone 60 min after inducing brain death in rats has been shown to modulate pulmonary inflammatory activity. Our objective was to evaluate the effects of methylprednisolone on transplanted rat lungs from donors treated 60 min after brain death.

Methods: Twelve Wistar rats were anesthetized, and brain death was induced. They were randomly divided into two groups (n=6), namely a control group, which was administered saline solution, and a methylprednisolone group, which received the drug 60 min after the induction of brain death. All of the animals were observed and ventilated for 2 h prior to being submitted to lung transplantation. We evaluated the hemodynamic and blood gas parameters, histological score, lung tissue levels of thiobarbituric acid-reactive substances, level of superoxide dismutase, level of tumor necrosis factor-alpha, and level of interleukin-1 beta.

Results: After transplantation, a significant reduction in the levels of tumor necrosis factor-alpha and IL-1β was observed in the group that received methylprednisolone (p=0.0084 and p=0.0155, respectively). There were no significant differences in tumor necrosis factor-alpha and superoxide dismutase levels between the control and methylprednisolone groups (p=0.2644 and p=0.7461, respectively). There were no significant differences in the blood gas parameters, hemodynamics, and histological alterations between the groups.

Conclusion: The administration of methylprednisolone after brain death in donor rats reduces inflammatory activity in transplanted lungs but has no influence on parameters related to oxidative stress.

Citing Articles

Oscillatory ventilation enhances oxygenation and reduces inflammation in an animal model of acute respiratory distress syndrome: an experimental study.

Forgiarini Junior L, Forgiarini L, Paludo A, Mariano R, de Moraes M, Felix E Braz J Anesthesiol. 2024; 75(1):844576.

PMID: 39586375 PMC: 11731209. DOI: 10.1016/j.bjane.2024.844576.


Methylprednisolone Treatment in Brain Death-Induced Lung Inflammation-A Dose Comparative Study in Rats.

van Zanden J, t Hart N, Ottens P, Liu B, Rebolledo R, Erasmus M Front Pharmacol. 2021; 12:587003.

PMID: 33692687 PMC: 7937885. DOI: 10.3389/fphar.2021.587003.


Anti-inflammatory and Antioxidant Effects of Captopril Compared to Methylprednisolone in L-Arginine-Induced Acute Pancreatitis.

El-Ashmawy N, Khedr N, El-Bahrawy H, Hamada O Dig Dis Sci. 2018; 63(6):1497-1505.

PMID: 29594979 DOI: 10.1007/s10620-018-5036-1.


Mechanical versus humoral determinants of brain death-induced lung injury.

Belhaj A, Dewachter L, Rorive S, Remmelink M, Weynand B, Melot C PLoS One. 2017; 12(7):e0181899.

PMID: 28753621 PMC: 5533440. DOI: 10.1371/journal.pone.0181899.

References
1.
Strieter R, Kunkel S . Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Investig Med. 1994; 42(4):640-51. View

2.
Follette D, Rudich S, Babcock W . Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant. 1998; 17(4):423-9. View

3.
Faropoulos K, Apostolakis E . Brain death and its influence on the lungs of the donor: how is it prevented?. Transplant Proc. 2009; 41(10):4114-9. DOI: 10.1016/j.transproceed.2009.09.087. View

4.
Kutsogiannis D, Pagliarello G, Doig C, Ross H, Shemie S . Medical management to optimize donor organ potential: review of the literature. Can J Anaesth. 2006; 53(8):820-30. DOI: 10.1007/BF03022800. View

5.
Avlonitis V, Fisher A, Kirby J, Dark J . Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation. 2003; 75(12):1928-33. DOI: 10.1097/01.TP.0000066351.87480.9E. View